Skip to main content

Table 6 Multivariate logistic regression analysis of factors affecting tumor response rate (ZIO 50%)

From: Prediction of breast cancer sensitivity to neoadjuvant chemotherapy based on status of DNA damage repair proteins

   Odds ratio (95% CI) P
After EC + DOC     
  Tumor stage    
     T2 1.000   
     T3 2.246 (0.290-17.420) 0.4388
  Nodal status    
     N- 1.000   
     N+ 3.651 (0.346-38.506) 0.2813
  Subtype    
     Luminal A, B 1.000   
     HER2, Basal-like 2.484 (0.464-13.287) 0.2874
  DDR score    
     0, 1, 2 1.000   
     3, 4 6.694 (1.088-41.182) 0.0402
  1. CI, confidence interval; DDR, DNA Damage Response; DOC, docetaxel; EC, epirubicin plus cyclophosphamide; HER, human epidermal growth factor receptor.